BB
BigHat Biosciences
United States · Biotech
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Product
BigHat combines machine learning with synthetic biology to design and optimize antibody candidates across multiple properties. Its platform generates experimental data for protein design, connecting computational models with laboratory work.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $75M | DFJ Growth — LeadPremji Invest — Lead8VC — ParticipantAlexandria Venture Investments — ParticipantAmgen Ventures — ParticipantAndreessen Horowitz (a16z) — ParticipantCatalio Capital Management — ParticipantDiscovery Ventures — ParticipantEli Lilly and Company — ParticipantGRIDS Capital — ParticipantIntermountain Ventures — ParticipantLG Technology Ventures — ParticipantMerck Global Health Innovation Fund — ParticipantQuadrille Capital — ParticipantS32 — ParticipantSigmas Group — Participant |